Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trialGeorge D. Demetri, Paolo G. Casali, Peter Hohenberger et al.|The Lancet|2012Cited by 1.4k
Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group StudyPaul Lorigan, Jean‐Yves Blay, Jaap Verweij et al.|Journal of Clinical Oncology|2007Cited by 256
Somatic mutations of KIT in familial testicular germ cell tumoursElizabeth Rapley, Michael R. Stratton, Sarah L. Hockley et al.|British Journal of Cancer|2004Cited by 96